Skip to main navigation Skip to search Skip to main content

Clinical characteristics of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia

  • Marissa O’callaghan
  • , Sarah H. Forde
  • , Alessandro N. Franciosi
  • , Maitreyi Penugonda
  • , Remi Diesler
  • , Helen O’brien
  • , Wieneke Buikhuisen
  • , Hussein Almeamar
  • , Bilal F. Samhouri
  • , Jay H. Ryu
  • , Marcel Veltkamp
  • , Effrosyni D. Manali
  • , Aggeliki Lazaratou
  • , Spyros A. Papiris
  • , Francesco Bonella
  • , Laurie Carr
  • , Vincent Cottin
  • , Camille Taille
  • , Francis X. McCormack
  • , Nishant Gupta
  • Jonathan Strosberg, Fillipo M. Lococo, Sergio Harari, Giuseppe Pelosi, Riccardo Papa, Demosthenes Bouros, Lykourgos Kolilekas, Zoe Daniil, Ilias Dimeas, Fernanda Hernandez-Gonzalez, Jacobo Sellares, Paolo Spagnolo, Rachel K. Crowley, Dermot O’ Toole, Donal O’shea, Sean Quinn, David J. Murphy, Aurelie Fabre, Adam J. Byrne, Michael P. Keane, Ludovic Fournel, Cormac McCarthy*
*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Downloads (Pure)

Abstract

Rationale Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is characterised by diffuse bronchial hyperplasia of pulmonary neuroendocrine cells, which are situated within the walls of bronchi and bronchioles. Presenting symptoms are nonspecific and the clinical course varies, making diagnosis challenging. We sought to describe the clinical characteristics of patients with DIPNECH in a large multinational case series to guide and inform future care and research. Methods Data were collated from 18 international centres. Information collected included disease presentation, pulmonary function testing, histopathology, radiological patterns and outcomes. The relationship between clinical features, radiology and symptoms were explored in parametric and nonparametric group-wise analyses, univariate linear regressions, and multivariate binomial logistic regression. Results The mean±SD age of the 258 patients in this study was 63.3±10.6 years and 93.4% were female. Diffuse pulmonary nodules (98.8%) and mosaic attenuation (59.1%) were the most common radiological findings and 29.5% had obstructive spirometry with a mean±SDforced expiratory volume in 1 s (FEV1)% pred of 69.0±23.7%. There was a significant association between the number of nodules and a reduction in FEV1 % pred (p<0.001), while the presence of bronchial wall thickening on imaging was most closely associated with cough (OR 4.97, p=0.001) dyspnoea (OR 3.14, p=0.003) and bronchodilator responsiveness (OR 3.09, p=0.013). Approximately half of patients treated with inhaled beta agonist and corticosteroids (46.3%) or somatostatin analogue (54.1%) reported improvement in symptoms. Conclusions The presence of radiological bronchial wall thickening is associated with the presence of symptoms, while mosaic attenuation is correlated with airflow obstruction; hence, the presence of these radiological findings has the potential to guide possible treatment decisions.

Original languageEnglish
Article number00829-2025
Number of pages14
JournalERJ Open Research
Volume12
Issue number1
DOIs
Publication statusPublished - Jan 2026

Fingerprint

Dive into the research topics of 'Clinical characteristics of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia'. Together they form a unique fingerprint.

Cite this